Your browser doesn't support javascript.
loading
The Clinically Approved Antifungal Drug Posaconazole Inhibits Human Cytomegalovirus Replication.
Mercorelli, Beatrice; Luganini, Anna; Celegato, Marta; Palù, Giorgio; Gribaudo, Giorgio; Lepesheva, Galina I; Loregian, Arianna.
Afiliación
  • Mercorelli B; Department of Molecular Medicine, University of Padua, Padua, Italy beatrice.mercorelli@unipd.it arianna.loregian@unipd.it.
  • Luganini A; Department of Life Sciences and Systems Biology, University of Turin, Turin, Italy.
  • Celegato M; Department of Molecular Medicine, University of Padua, Padua, Italy.
  • Palù G; Department of Molecular Medicine, University of Padua, Padua, Italy.
  • Gribaudo G; Department of Life Sciences and Systems Biology, University of Turin, Turin, Italy.
  • Lepesheva GI; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Loregian A; Department of Molecular Medicine, University of Padua, Padua, Italy beatrice.mercorelli@unipd.it arianna.loregian@unipd.it.
Antimicrob Agents Chemother ; 64(10)2020 09 21.
Article en En | MEDLINE | ID: mdl-32690644
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Infecciones por Citomegalovirus Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Antimicrob Agents Chemother Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Infecciones por Citomegalovirus Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Antimicrob Agents Chemother Año: 2020 Tipo del documento: Article